Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Am J Obstet Gynecol. 2014 Jun 19;211(6):627.e1–627.e9. doi: 10.1016/j.ajog.2014.06.036

TABLE 4.

Hazard of death for black women who were diagnosed with endometrial cancera

Variable Unadjusted
Adjusted
Model 1b
Model 2c
Hazard ratio for black race (95% confidence interval) P value Hazard ratio for black race (95% confidence interval) P value Hazard ratio for black race (95% confidence interval) P value
All cases
 Overall 1.51 (1.22–1.87) < .001 1.29 (1.02–1.63) .036 1.22 (0.94–1.57) .134
 Disease-specific 2.42 (1.63–3.60) < .001 2.11 (1.35–3.30) .001 2.27 (1.39–3.68) .001
Surgically treated cases
 Overall 1.39 (1.11–1.75) .005 1.28 (1.00–1.64) .051 1.26 (0.97–1.64) .082
 Disease-specific 2.15 (1.39–3.32) < .001 2.03 (1.27–3.24) .003 2.19 (1.32–3.64) .002
a

Compared with white women at a single institution;

b

Adjusted for year and age at diagnosis, Federation of International Gynecologists and Obstetricians stage, grade, histologic type, receipt of chemotherapy, radiation therapy and, in “all cases,” surgery;

c

Adjusted for year and age at diagnosis, Federation of International Gynecologists and Obstetricians stage, grade, histologic type, receipt of chemotherapy, radiation therapy, diabetes mellitus, hypertension, obesity, Charlson comorbidity index, and, in “all cases,” surgery.

Ruterbusch. Race, comorbidities, and endometrial cancer survival. Am J Obstet Gynecol 2014.